Profile
Donald A.
Johnson worked as a Senior Vice President at Algos Pharmaceutical Corp.
and as a Vice President-Analytical Services at Pharmaceutics International, Inc. He received his undergraduate, graduate, and doctorate degrees from the University of Wisconsin in 1985.
Former positions of Donald A. Johnson
| Companies | Position | End |
|---|---|---|
Algos Pharmaceutical Corp.
 Algos Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Part of Endo International Plc, Algos Pharmaceutical Corp. develops and makes pain management products including narcotic drugs. The company is based in Neptune, NJ. Algos Pharmaceutical was acquired by Endo Health Solutions, Inc. on July 17, 2000 for $243.89 million. | Corporate Officer/Principal | - |
Pharmaceutics International, Inc.
 Pharmaceutics International, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceutics International, Inc. develops and manufactures pharmaceuticals dosage and ingredients. It specializes in solid dispersion development and lipid-or micro/nano-based emulsions. The company was founded in 1994 and is headquartered in Hunt Valley, MD. | Corporate Officer/Principal | - |
Training of Donald A. Johnson
| University of Wisconsin | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Pharmaceutics International, Inc.
Pharmaceutics International, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceutics International, Inc. develops and manufactures pharmaceuticals dosage and ingredients. It specializes in solid dispersion development and lipid-or micro/nano-based emulsions. The company was founded in 1994 and is headquartered in Hunt Valley, MD. | Health Technology |
Algos Pharmaceutical Corp.
Algos Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Part of Endo International Plc, Algos Pharmaceutical Corp. develops and makes pain management products including narcotic drugs. The company is based in Neptune, NJ. Algos Pharmaceutical was acquired by Endo Health Solutions, Inc. on July 17, 2000 for $243.89 million. | Health Technology |
- Stock Market
- Insiders
- Donald A. Johnson